EUVIMEDEUVIMED entdecken
Crossref

Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor

Michael Benedict Subhahar, Abdul Khader Karakka Kal iD, Moses Philip, Meleparappil Muhammed Ajeebsanu, Tajudheen K Karatt, Zubair Perwad

Rapid Communications in Mass Spectrometry · 2024

DOI: 10.1002/rcm.9671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2024. Verfasst von Michael Benedict Subhahar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Doping in Sports, Anemia, Sickle Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Sickle cell disease, a debilitating genetic disorder affecting numerous newborns globally, has historically received limited attention in pharmaceutical research. However, recent years have witnessed a notable shift, with the Food and Drug Administration approving three innovative disease‐modifying medications. Voxelotor, also known as GBT440, is a promising compound that effectively prevents sickling, providing a safe approach to alleviate chronic hemolytic anemia in sickle cell disease. It is a novel, orally bioavailable small molecule that inhibits hemoglobin S polymerization by enhancing oxygen affinity to hemoglobin. The investigation demonstrated that voxelotor led to an unintended elevation of hemoglobin levels in healthy individuals by increasing serum erythropoietin levels.

Methods

Voxelotor and its metabolites in an in vitro setting utilizing equine liver microsomes were discussed. Plausible structures of the identified metabolites were inferred through the application of liquid chromatography in conjunction with high‐resolution mass spectrometry.

Results

Under the experimental conditions, a total of 31 metabolites were detected, including 16 phase I metabolites, two phase II metabolites, and 13 conjugates of phase I metabolites. The principal phase I metabolites were generated through processes such as hydroxylation, reduction, and dissociation. The presence of glucuronide and sulfate conjugates of the parent drug were also observed, along with hydroxylated, reduced, and dissociated analogs.

Conclusions

The data acquired will accelerate the identification of voxelotor and related compounds, aiding in the detection of their illicit use in competitive sports. It is crucial to emphasize that the metabolites detailed in this manuscript were identified through in vitro experiments and their detection in an in vivo study may not be guaranteed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsAnemia, Sickle CellInfant, NewbornHumansAnimalsHorsesHemoglobin, SicklePolymerizationBenzaldehydesHemoglobinsPyrazinesPyrazoles

Substanzen

Hemoglobin, SickleBenzaldehydesHemoglobinsvoxelotorPyrazinesPyrazoles

Autor:innen und Institutionen

  • Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, United Arab Emirates.

ORCID-Profile: Abdul Khader Karakka Kal

Zitieren

APA

Subhahar, M. B., Karakka Kal, A. K., Philip, M., Muhammed Ajeebsanu, M., Karatt, T. K., & Perwad, Z. (2024). Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9671

Vancouver

Subhahar MB, Karakka Kal AK, Philip M, Muhammed Ajeebsanu M, Karatt TK, Perwad Z. Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor. Rapid Communications in Mass Spectrometry. 2024. doi:10.1002/rcm.9671

BibTeX
@article{Subhahar2024,
  author = {Subhahar, Michael Benedict and Karakka Kal, Abdul Khader and Philip, Moses and Muhammed Ajeebsanu, Meleparappil and Karatt, Tajudheen K and Perwad, Zubair},
  title = {Doping control approach: Identification of equine in vitro metabolites of voxelotor (GBT440), a hemoglobin S polymerization inhibitor},
  journal = {Rapid Communications in Mass Spectrometry},
  year = {2024},
  doi = {10.1002/rcm.9671}
}
Kostenlos starten →